PRESTWICK PHARMACEUTICALS
Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases. The company offers products for restless legs syndrome, schizophrenia, autism, Alzheimer’s, and sleep apnea ailments. Prestwick Pharmaceuticals was founded in 2002 and is based in Washington, District of Columbia.
PRESTWICK PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2002-01-01
Address:
Washington, District Of Columbia, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
132 M USD
Similar Organizations
Prolong Pharmaceuticals
Prolong Pharmaceuticals develops and markets biopharmaceutical products for the treatment of various diseases.
Proventiv Therapeutics
Proventiv Therapeutics develops and commercializes pharmaceutical products to treat and prevent the clinical consequences of diseases.
Resolvyx Pharmaceuticals
Resolvyx Pharmaceuticals develops therapeutics with small molecule lipid mediators for the treatment of inflammatory diseases.
Current Employees Featured
Investors List
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Prestwick Pharmaceuticals
Scale Venture Partners
Scale Venture Partners investment in Venture Round - Prestwick Pharmaceuticals
Warburg Pincus
Warburg Pincus investment in Venture Round - Prestwick Pharmaceuticals
Vivo Capital
Vivo Capital investment in Venture Round - Prestwick Pharmaceuticals
Atlas Venture
Atlas Venture investment in Venture Round - Prestwick Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series C - Prestwick Pharmaceuticals
Pequot Capital
Pequot Capital investment in Series C - Prestwick Pharmaceuticals
CNF Investments, LLC
CNF Investments, LLC investment in Series C - Prestwick Pharmaceuticals
Scale Venture Partners
Scale Venture Partners investment in Series C - Prestwick Pharmaceuticals
Vivo Capital
Vivo Capital investment in Series C - Prestwick Pharmaceuticals
More informations about "Prestwick Pharmaceuticals"
Prestwick Pharmaceuticals - Crunchbase Company Profile & Funding
Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases. Search Crunchbase Start Free TrialSee details»
Prestwick Pharmaceuticals - Funding, Financials, Valuation
Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases. Search Crunchbase. Start Free Trial . ... How much funding …See details»
Prestwick Pharmaceuticals - PitchBook
Prestwick Pharmaceuticals General Information Description. Developer of small molecule drugs for chronic diseases of the central nervous system (CNS). The company focuses on restless legs syndrome, schizophrenia, autism, …See details»
Prestwick Pharmaceuticals Inc - Company Profile and News
Prestwick Pharmaceuticals, Inc. provides specialty pharmaceutical products, and also develops and markets therapies for central nervous system disorders. The Company's current portfolio …See details»
Prestwick Pharmaceuticals - Company Profile - Tracxn
Nov 5, 2024 Prestwick Pharmaceuticals - Developing small molecule drugs to treat chronic CNS diseases. Acquired by Biovail. Raised a total funding of $112M over 6 rounds from 7 investors. …See details»
Biovail Acquires Prestwick Pharmaceuticals – Bausch Health …
Sep 17, 2008 Under the terms of the agreement, Biovail has paid $100 million to acquire 100% of Prestwick Pharmaceuticals, Inc. and related license rights. Beyond Xenazine(R), the …See details»
Prestwick Pharmaceuticals Inc - CareersInPharmaceutical.com
Prestwick Pharmaceuticals Inc. Address: 1825 K St NW Ste 1475 Washington, DC 20006 Phone: 202-296-1400 ... Alzheimer’s Disease and sleep apnea. Prestwick has a fully staffed sales and …See details»
Prestwick Pharmaceuticals - Crunchbase
Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases.See details»
Organization: Prestwick Pharmaceuticals - Cbonds.com
Organization: Prestwick Pharmaceuticals Organization name. Prestwick Pharmaceuticals Inc. Country name. USA Country of registration. USA. Industry. Pharmaceutical Preparation and …See details»
Prestwick Pharmaceuticals - CB Insights
Explore {Prestwick Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Technology …See details»
Biovail Acquires Prestwick Pharmaceuticals - bionity.com
Sep 19, 2008 Under the terms of the agreement, Biovail has paid $100 million to acquire 100% of Prestwick Pharmaceuticals, Inc. and related license rights. Beyond Xenazine®, the …See details»
Prestwick Pharmaceuticals - Products, Competitors, Financials ...
Headquarters Location. 1825 K Street North West Suite 1475. Washington, DC, 20006, United States. 202-296-1400See details»
Biovail buys Prestwick, gains CNS drugs | Fierce Biotech
Sep 17, 2008 Canada's Biovail has bought out U.S.-based Prestwick Pharmaceuticals, which recently won FDA approval for Xenazine. The orphan drug is a treatment for chorea, which is …See details»
Prestwick Pharmaceuticals - Contacts, Employees, Board Members ...
Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases. Search Crunchbase Start Free TrialSee details»
Annual Report on Prestwick Pharmaceuticals's Revenue, Growth, …
Determine whether Prestwick Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how …See details»
Biovail Corporation Acquires Prestwick Pharmaceuticals
Sep 17, 2008 TORONTO -- Biovail Corporation today announced it has acquired Prestwick Pharmaceuticals, Inc., a privately held, U.S.-based pharmaceutical company that holds the …See details»
Robert S. Radie - Orcosa
Before joining Prestwick Pharmaceuticals, he served in senior management positions with a number of pharmaceutical and biotechnology companies, including Morphotek, Inc., Vicuron …See details»
Prestwick Pharmaceuticals, Inc.'s XENAZINE(R) Approved by
WASHINGTON, Aug. 15 /PRNewswire/ -- Prestwick Pharmaceuticals, Inc., a privately-held pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) …See details»
William Washecka - CFO @ Prestwick Pharmaceuticals - Crunchbase
William Washecka is the chief financial officer of Prestwick Pharmaceuticals, a company that develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems …See details»